federal_register: E9-24716
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E9-24716 | New Animal Drugs for Use in Animal Feeds; Monensin; Tylosin | Rule | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health, A Division of Eli Lilly & Co. The supplemental NADA revises limitations for liquid Type B medicated cattle feeds containing tylosin phosphate. | 2009-10-15 | 2009 | 10 | https://www.federalregister.gov/documents/2009/10/15/E9-24716/new-animal-drugs-for-use-in-animal-feeds-monensin-tylosin | https://www.govinfo.gov/content/pkg/FR-2009-10-15/pdf/E9-24716.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health, A Division of Eli Lilly & Co. The supplemental NADA revises... |